Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

251.15
-7.2000-2.79%
Post-market: 251.150.00000.00%17:28 EDT
Volume:656.36K
Turnover:166.30M
Market Cap:32.75B
PE:-119.69
High:260.00
Open:259.92
Low:250.35
Close:258.35
Loading ...

Alnylam Pharmaceuticals Inc : Stifel Raises Target Price to $345 From $300

THOMSON REUTERS
·
31 Mar

Alnylam Pharmaceuticals Inc : Scotiabank Raises Target Price to $342 From $338

THOMSON REUTERS
·
31 Mar

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip

Simply Wall St.
·
30 Mar

BUZZ-U.S. STOCKS ON THE MOVE-SurgePays, B. Riley, CarMax

Reuters
·
27 Mar

BUZZ-Pfizer's heart disease drug remains 'mainstay treatment' despite new entries, Oppenheimer says

Reuters
·
26 Mar

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)

TIPRANKS
·
26 Mar

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?

Zacks
·
24 Mar

Alnylam Pharmaceuticals Raised to Overweight From Neutral by JP Morgan

Dow Jones
·
24 Mar

JPMorgan Upgrades Alnylam Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $328 From $280

MT Newswires Live
·
24 Mar

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy

Reuters
·
24 Mar

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Sees 17% Weekly Gain As Vutrisiran Faces FDA Decision

Simply Wall St.
·
24 Mar

Alnylam price target raised to $338 from $300 at Scotiabank

TipRanks
·
22 Mar

Alnylam Pharma Stock (ALNY) Rockets on FDA Drug Approval

TIPRANKS
·
22 Mar

Alnylam Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
22 Mar

Alnylam Stock Jumps After the FDA Approves Its Heart Drug -- WSJ

Dow Jones
·
22 Mar

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

Zacks
·
22 Mar

BUZZ-U.S. STOCKS ON THE MOVE-ACNB, Carnival Corp, Boeing

Reuters
·
21 Mar

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?

Zacks
·
21 Mar

Alnylam Pharmaceuticals Shares up 4% After FDA Expands Approval for Drug to Treat Rare Heart Disease

THOMSON REUTERS
·
21 Mar

Alnylam Pharmaceuticals Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
21 Mar